Century Therapeutics (IPSC) Payables (2020 - 2026)
Century Therapeutics (IPSC) posted quarterly Payables of $3.2 million for Q1 2026, down 11.84% year-over-year from $3.6 million in Q1 2025, and down 34.0% quarter-over-quarter from $4.8 million in Q4 2025.
Century Therapeutics (IPSC) Payables (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported Payables for 7 consecutive years, with $3.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Payables fell 11.84% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $3.2 million (down 11.84% YoY), while the FY2025 annual figure was $4.8 million, up 55.22% from the prior year.
- Payables fell to $3.2 million in Q1 2026 per IPSC's latest filing, from $4.8 million in the prior quarter.
- Across five years, Payables topped out at $9.9 million in Q1 2022 and bottomed at $2.6 million in Q3 2024.
- Historically, Payables has averaged $4.2 million across 5 years, with a median of $3.5 million in 2023.
- Annual changes were most pronounced in 2022 — Payables tumbled 69.85% — and 2025, when it surged 55.22%.
- Century Therapeutics' Payables stood at $5.5 million in 2022, then tumbled by 49.74% to $2.7 million in 2023, then rose by 12.19% to $3.1 million in 2024, then soared by 55.22% to $4.8 million in 2025, then slumped by 34.0% to $3.2 million in 2026.
- Business Quant data shows IPSC's Payables at $3.2 million in Q1 2026, $4.8 million in Q4 2025, and $2.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - | 4.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.82 Mn |
| Mar 31, 2026 | 3.15 Mn |
| Dec 31, 2025 | 4.77 Mn |
| Sep 30, 2025 | 2.62 Mn |
| Jun 30, 2025 | 3.21 Mn |
| Mar 31, 2025 | 3.57 Mn |
| Dec 31, 2024 | 3.08 Mn |
| Sep 30, 2024 | 2.60 Mn |
| Jun 30, 2024 | 3.36 Mn |
| Mar 31, 2024 | 3.43 Mn |
| Dec 31, 2023 | 2.74 Mn |
| Sep 30, 2023 | 5.93 Mn |
| Jun 30, 2023 | 3.63 Mn |
| Mar 31, 2023 | 3.48 Mn |
| Dec 31, 2022 | 5.45 Mn |
| Sep 30, 2022 | 5.69 Mn |
| Jun 30, 2022 | 4.05 Mn |
| Mar 31, 2022 | 9.89 Mn |
| Dec 31, 2021 | 7.60 Mn |
| Sep 30, 2021 | 11.64 Mn |